Get 40% Off
💰 Ray Dalio just increased his holdings in Google by 162.61% - See the full portfolio with InvestingPro’s free Stock Ideas toolCopy Portfolios

BRIEF-Miravo Healthcare Ireland Enters Into Suvexx® License And Supply Agreement With Orion Corporation For Select EU Markets

Published 2020-12-21, 11:18 a/m
© Reuters.
MRV
-

Dec 21 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :

* MIRAVO HEALTHCARE™ IRELAND ENTERS INTO SUVEXX® LICENSE AND SUPPLY AGREEMENT WITH ORION CORPORATION FOR SELECT EU MARKETS

* NUVO PHARMACEUTICALS INC - UP TO EUR 1.7 MILLION IN UPFRONT AND MILESTONE PAYMENTS

* NUVO PHARMACEUTICALS INC - COMMERCIAL LAUNCH OF SUVEXX IN TERRITORY IS ANTICIPATED TO COMMENCE IN 2022, SUBJECT TO REGULATORY APPROVAL

* NUVO PHARMACEUTICALS INC - LICENSE AGREEMENT GRANTS ORION EXCLUSIVE RIGHTS TO PACKAGE, MARKET, SELL AND DISTRIBUTE SUVEXX IN TERRITORY

* NUVO PHARMACEUTICALS INC - ORION WILL BE RESPONSIBLE FOR OBTAINING AND MAINTAINING MARKETING AUTHORIZATIONS FOR SUVEXX IN TERRITORY

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.